Pricing
Login
Home
Charts
Search
Watchlist
Products

Astrazeneca Pharma India Ltd

ASTRAZEN
₹6,167.50+0.89%20 Nov 2026
Reports
Pharma MNC Bulk Drugs

Astrazeneca Pharma India Ltd

ASTRAZEN
₹6,167.50
+0.89%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹15,419Cr
Close
Close Price
₹6,167.50
Industry
Industry
Pharma MNC Bulk Drugs
PE
Price To Earnings
86.76
PS
Price To Sales
5.93
Revenue
Revenue
₹2,602Cr
Rev Gr TTM
Revenue Growth TTM
29.70%
PAT Gr TTM
PAT Growth TTM
-10.76%

Quarterly Results

Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
306383388408440480526559612579683729
Growth YoY
Revenue Growth YoY%
22.434.631.131.244.025.435.837.038.920.429.730.4
Expenses
ExpensesCr
291334349355363394445484567518634634
Operating Profit
Operating ProfitCr
154938537786817545614996
OPM
OPM%
4.912.99.812.917.518.015.413.47.310.57.213.1
Other Income
Other IncomeCr
109-498-26101117590
Interest Expense
Interest ExpenseCr
100001111222
Depreciation
DepreciationCr
44499181734655
PBT
PBTCr
2054-15514278757347585188
Tax
TaxCr
515-3131120191914131326
PAT
PATCr
1639-12383158565433453862
Growth YoY
PAT Growth YoY%
-46.1128.6-121.9-26.695.347.5573.541.15.6-22.9-32.115.0
NPM
NPM%
5.210.3-3.09.47.012.110.69.75.37.85.68.6
EPS
EPS₹
6.315.8-4.716.412.323.322.321.713.017.915.224.9
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
306383388408440480526559612579683729
Growth YoY
Revenue Growth YoY%
22.434.631.131.244.025.435.837.038.920.429.730.4
Expenses
ExpensesCr
291334349355363394445484567518634634
Operating Profit
Operating ProfitCr
154938537786817545614996
OPM
OPM%
4.912.99.812.917.518.015.413.47.310.57.213.1
Other Income
Other IncomeCr
109-498-26101117590
Interest Expense
Interest ExpenseCr
100001111222
Depreciation
DepreciationCr
44499181734655
PBT
PBTCr
2054-15514278757347585188
Tax
TaxCr
515-3131120191914131326
PAT
PATCr
1639-12383158565433453862
Growth YoY
PAT Growth YoY%
-46.1128.6-121.9-26.695.347.5573.541.15.6-22.9-32.115.0
NPM
NPM%
5.210.3-3.09.47.012.110.69.75.37.85.68.6
EPS
EPS₹
6.315.8-4.716.412.323.322.321.713.017.915.224.9

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5645445717288328148061,0031,2961,7162,2762,602
Growth
Revenue Growth%
9.0-3.55.027.614.2-2.2-1.024.529.232.532.629.7
Expenses
ExpensesCr
5475075256577116787198381,1111,4622,0142,352
Operating Profit
Operating ProfitCr
1637467112113586165184254262250
OPM
OPM%
2.96.88.19.814.516.610.716.514.214.811.59.6
Other Income
Other IncomeCr
7141216131315-1451-562321
Interest Expense
Interest ExpenseCr
000011111147
Depreciation
DepreciationCr
171615151920171615402920
PBT
PBTCr
636447311412783134220156252244
Tax
TaxCr
11518184234213558416566
PAT
PATCr
520265472936299162116188178
Growth
PAT Growth%
125.2281.329.2110.232.629.2-34.061.262.7-28.362.0-10.8
NPM
NPM%
0.93.74.57.58.711.57.79.912.56.78.26.8
EPS
EPS₹
2.18.010.421.828.937.324.639.764.646.375.071.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5645445717288328148061,0031,2961,7162,2762,602
Growth
Revenue Growth%
9.0-3.55.027.614.2-2.2-1.024.529.232.532.629.7
Expenses
ExpensesCr
5475075256577116787198381,1111,4622,0142,352
Operating Profit
Operating ProfitCr
1637467112113586165184254262250
OPM
OPM%
2.96.88.19.814.516.610.716.514.214.811.59.6
Other Income
Other IncomeCr
7141216131315-1451-562321
Interest Expense
Interest ExpenseCr
000011111147
Depreciation
DepreciationCr
171615151920171615402920
PBT
PBTCr
636447311412783134220156252244
Tax
TaxCr
11518184234213558416566
PAT
PATCr
520265472936299162116188178
Growth
PAT Growth%
125.2281.329.2110.232.629.2-34.061.262.7-28.362.0-10.8
NPM
NPM%
0.93.74.57.58.711.57.79.912.56.78.26.8
EPS
EPS₹
2.18.010.421.828.937.324.639.764.646.375.071.1
Sales CAGR
1 Year33%
3 Years31%
5 Years23%
TTM30%
EBITDA CAGR
1 Year3%
3 Years17%
5 Years14%
TTM-22%
PAT CAGR
1 Year62%
3 Years24%
5 Years15%
TTM-11%
Avg. ROCE
1 Year26%
3 Years25%
5 Years23%
TTM29%
CFO / EBITDA
1 Year-6%
3 Years11%
5 Years25%
TTM-

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
555555555555
Reserves
ReservesCr
151218242296359451506584707765868874
Current Liabilities
Current LiabilitiesCr
2341902072593273043333843577039821,190
Non Current Liabilities
Non Current LiabilitiesCr
1327215151312945135123
Total Liabilities
Total LiabilitiesCr
4034154615627067758579851,0781,5181,9892,191
Current Assets
Current AssetsCr
2672523214055426197068359331,3421,7401,940
Non Current Assets
Non Current AssetsCr
136164140157164156151149145176249251
Total Assets
Total AssetsCr
4034154615627067758579851,0781,5181,9892,191
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
555555555555
Reserves
ReservesCr
151218242296359451506584707765868874
Current Liabilities
Current LiabilitiesCr
2341902072593273043333843577039821,190
Non Current Liabilities
Non Current LiabilitiesCr
1327215151312945135123
Total Liabilities
Total LiabilitiesCr
4034154615627067758579851,0781,5181,9892,191
Current Assets
Current AssetsCr
2672523214055426197068359331,3421,7401,940
Non Current Assets
Non Current AssetsCr
136164140157164156151149145176249251
Total Assets
Total AssetsCr
4034154615627067758579851,0781,5181,9892,191

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
573895587105101582865-15
Investing Cash Flow
Investing Cash FlowCr
-40-94-171173518223119
Financing Cash Flow
Financing Cash FlowCr
-1000-6-9-9-24-44-66-92
Net Cash Flow
Net Cash FlowCr
5338-159-902699652531-88
Free Cash Flow
Free Cash FlowCr
4833337749994531864-18
CFO To PAT
CFO To PAT%
1,083.6190.033.9101.0121.1112.3163.658.717.356.5-8.1
CFO To EBITDA
CFO To EBITDA%
347.1103.119.077.172.477.3117.035.315.125.7-5.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
573895587105101582865-15
Investing Cash Flow
Investing Cash FlowCr
-40-94-171173518223119
Financing Cash Flow
Financing Cash FlowCr
-1000-6-9-9-24-44-66-92
Net Cash Flow
Net Cash FlowCr
5338-159-902699652531-88
Free Cash Flow
Free Cash FlowCr
4833337749994531864-18
CFO To PAT
CFO To PAT%
1,083.6190.033.9101.0121.1112.3163.658.717.356.5-8.1
CFO To EBITDA
CFO To EBITDA%
347.1103.119.077.172.477.3117.035.315.125.7-5.8

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,8922,3522,3164,9965,9797,5266,3898,11813,30121,51619,39915,419
Price To Earnings
Price To Earnings
550.8117.389.491.882.880.7103.781.882.4185.9103.586.8
Price To Sales
Price To Sales
5.14.34.16.97.29.37.98.110.312.58.55.9
Price To Book
Price To Book
18.510.69.416.616.416.512.513.818.727.922.217.5
EV To EBITDA
EV To EBITDA
171.460.547.367.647.553.069.046.269.482.872.759.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
61.565.265.565.861.361.759.362.252.642.538.338.3
OPM
OPM%
2.96.88.19.814.516.610.716.514.214.811.59.6
NPM
NPM%
0.93.74.57.58.711.57.79.912.56.78.26.8
ROCE
ROCE%
3.715.917.724.230.627.416.122.630.819.626.128.5
ROE
ROE%
3.49.010.518.119.820.412.116.922.715.021.520.2
ROA
ROA%
1.34.85.69.710.212.07.210.115.07.69.48.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,8922,3522,3164,9965,9797,5266,3898,11813,30121,51619,39915,419
Price To Earnings
Price To Earnings
550.8117.389.491.882.880.7103.781.882.4185.9103.586.8
Price To Sales
Price To Sales
5.14.34.16.97.29.37.98.110.312.58.55.9
Price To Book
Price To Book
18.510.69.416.616.416.512.513.818.727.922.217.5
EV To EBITDA
EV To EBITDA
171.460.547.367.647.553.069.046.269.482.872.759.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
61.565.265.565.861.361.759.362.252.642.538.338.3
OPM
OPM%
2.96.88.19.814.516.610.716.514.214.811.59.6
NPM
NPM%
0.93.74.57.58.711.57.79.912.56.78.26.8
ROCE
ROCE%
3.715.917.724.230.627.416.122.630.819.626.128.5
ROE
ROE%
3.49.010.518.119.820.412.116.922.715.021.520.2
ROA
ROA%
1.34.85.69.710.212.07.210.115.07.69.48.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr56,36446,20717,64015,4199,2787,9287,384
Close PriceClose₹26,525.002,727.603,856.006,167.505,589.503,442.403,206.10
IndustryIndustryPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk Drugs
Price To EarningsPE34.1040.8520.5386.7624.4328.3520.26
Price To SalesPS7.8311.116.655.936.228.104.05
RevenueRevenueCr7,1984,1592,6542,6021,4919791,822
Revenue Growth TTMRev Gr TTM%7.2%12.1%11.8%29.7%16.1%22.7%-5.7%
PAT Growth TTMPAT Gr TTM%9.5%20.0%2.4%-10.8%23.8%28.4%2.3%
Market CapitalizationMkt CapCr56,36446,20717,64015,4199,2787,9287,384
Close PriceClose₹26,525.002,727.603,856.006,167.505,589.503,442.403,206.10
IndustryIndustryPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk Drugs
Price To EarningsPE34.1040.8520.5386.7624.4328.3520.26
Price To SalesPS7.8311.116.655.936.228.104.05
RevenueRevenueCr7,1984,1592,6542,6021,4919791,822
Revenue Growth TTMRev Gr TTM%7.2%12.1%11.8%29.7%16.1%22.7%-5.7%
PAT Growth TTMPAT Gr TTM%9.5%20.0%2.4%-10.8%23.8%28.4%2.3%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
ResultPPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Jun 23
ResultPPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
ResultPPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Jun 23
ResultPPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Load More
Interviews